Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 05, 2015 2:23 PM ET


Company Overview of Emerillon Therapeutics Inc.

Executive Profile

Lisa McKerracher Ph.D.

Chief Executive Officer, Emerillon Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Lisa McKerracher, Ph.D. serves as Chief Executive Officer of Emerillon Therapeutics Inc. Dr. McKerracher focuses on Emerillon 's drug development for treatment of infectious disease. Dr. McKerracher is recognized as an expert in translational Neuroscience. She co-founded BioAxone Therapeutic, Inc. in 2000 and served as its President and Chief Scientific Officer. Dr. McKerracher serves as a Director of BioAxone Therapeutic, Inc. She is a Member of the Institute Advisory ...

Corporate Headquarters

416 de Maisonneuve West
Montréal, Quebec H3A 1L2


Phone: 514-985-0306
Fax: 514-985-0012

Board Members Memberships

Co-Founder and Director


PhD 1985
York University
BS 1981
McGill University
Post-Doctoral Training
Worcester Foundation for Biomedical Research

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Emerillon Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at